{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:23:34Z","timestamp":1792614214299,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T00:00:00Z","timestamp":1377820800000},"content-version":"vor","delay-in-days":333,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.jneuroim.2012.06.003","type":"journal-article","created":{"date-parts":[[2012,7,3]],"date-time":"2012-07-03T12:06:50Z","timestamp":1341317210000},"page":"73-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Disease-specific expression of the serotonin-receptor 5-HT2C in natural killer cells in Alzheimer's dementia"],"prefix":"10.1016","volume":"251","author":[{"given":"Luiza Concei\u00e7\u00e3o Amorim","family":"Martins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nat\u00e1lia Pessoa","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen Cec\u00edlia Lima","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Ribeiro","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giselle Sabrina","family":"Fran\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar Nunes","family":"de Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marat Alexandrovich","family":"Mukhamedyarov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey Lvovich","family":"Zefirov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert Anatolyevich","family":"Rizvanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey Pavlovich","family":"Kiyasov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciene Bruno","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa Monteiro","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Emir","family":"Yalva\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f4nio L\u00facio","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Aparecida Camargo","family":"Bicalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Janka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Aur\u00e9lio","family":"Romano-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e1s","family":"Palot\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helton Jos\u00e9","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jneuroim.2012.06.003_bb0005","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jalz.2011.02.004","article-title":"Alzheimer's disease facts and figures","volume":"7","author":"Alzheimer's Association","year":"2011","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.jneuroim.2012.06.003_bb0010","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1471-4159.2011.07545.x","article-title":"Cells, biomarkers, and post-traumatic stress disorder: evidence for peripheral involvement in a central disease","volume":"120","author":"Andrews","year":"2012","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.jneuroim.2012.06.003_bb0015","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/archneur.1990.00530040020007","article-title":"Natural killer cell activity in patients with dementia of the Alzheimer type","volume":"47","author":"Araga","year":"1990","journal-title":"Arch. Neurol."},{"issue":"3","key":"10.1016\/j.jneuroim.2012.06.003_bb0020","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1600-0404.1991.tb04948.x","article-title":"Reduced natural killer cell activity in patients with dementia of the Alzheimer type","volume":"84","author":"Araga","year":"1991","journal-title":"Acta Neurol. Scand."},{"issue":"1\u20133","key":"10.1016\/j.jneuroim.2012.06.003_bb0025","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0047-6374(00)00183-4","article-title":"Reduced density of dopamine D2-like receptors on peripheral blood lymphocytes in Alzheimer's disease","volume":"120","author":"Barbanti","year":"2000","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.jneuroim.2012.06.003_bb0030","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.7046051","article-title":"The cholinergic hypothesis of geriatric memory dysfunction","volume":"217","author":"Bartus","year":"1982","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.jneuroim.2012.06.003_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/S0004-282X1994000100001","article-title":"The mini-mental state examination in a general population: impact of educational status","volume":"52","author":"Bertolucci","year":"1994","journal-title":"Arq. Neuropsiquiatr."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2012.06.003_bb0040","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jneuroim.2005.11.018","article-title":"D3 dopamine receptor mRNA is elevated in T cells of schizophrenic patients whereas D4 dopamine receptor mRNA is reduced in CD4+ T cells","volume":"173","author":"Boneberg","year":"2006","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.jneuroim.2012.06.003_bb0045","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jalz.2009.12.004","article-title":"Drug treatment of Alzheimer's disease patients leads to expression changes in peripheral blood cells","volume":"6","author":"Calciano","year":"2010","journal-title":"Alzheimers Dement."},{"issue":"4","key":"10.1016\/j.jneuroim.2012.06.003_bb0050","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3233\/JAD-2011-110002","article-title":"Disturbed neurotransmitter transporter expression in Alzheimer's disease brain","volume":"26","author":"Chen","year":"2011","journal-title":"J. Alzheimers Dis."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2012.06.003_bb0055","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.imlet.2011.06.011","article-title":"Antipsychotic drugs suppress the AKT\/NF-\u03baB pathway and regulate the differentiation of T-cell subsets","volume":"140","author":"Chen","year":"2011","journal-title":"Immunol. Lett."},{"issue":"5","key":"10.1016\/j.jneuroim.2012.06.003_bb0060","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0165-6147(98)01202-4","article-title":"Fibroblast models of neurological disorders: fluorescence measurement studies","volume":"19","author":"Connolly","year":"1998","journal-title":"Trends Pharmacol. Sci."},{"issue":"10","key":"10.1016\/j.jneuroim.2012.06.003_bb0065","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/2677","article-title":"HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy","volume":"4","author":"Corder","year":"1998","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.jneuroim.2012.06.003_bb0070","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0197-0186(88)90107-6","article-title":"An autoradiographic analysis of serotonin receptors in human temporal cortex: changes in Alzheimer-type dementia","volume":"13","author":"Cross","year":"1988","journal-title":"Neurochem. Int."},{"issue":"2 Suppl. 1","key":"10.1016\/j.jneuroim.2012.06.003_bb0075","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1097\/00019442-199821001-00009","article-title":"The cholinergic hypothesis of neuropsychiatric symptoms in Alzheimer's disease","volume":"6","author":"Cummings","year":"1998","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"2","key":"10.1016\/j.jneuroim.2012.06.003_bb0080","first-page":"82","article-title":"Diagnosis of neurometabolic disorders by examination of skin biopsies and lymphocytes","volume":"1","author":"Dolman","year":"1984","journal-title":"Semin. Diagn. Pathol."},{"key":"10.1016\/j.jneuroim.2012.06.003_bb0085","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","article-title":"Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS\u2013ADRDA criteria","volume":"6","author":"Dubois","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2012.06.003_bb0090","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0369-8114(00)00009-2","article-title":"\u03b2-amyloid protein aggregation: its implication in the physiopathology of Alzheimer's disease","volume":"49","author":"Dumery","year":"2001","journal-title":"Pathol. Biol. (Paris)"},{"issue":"6","key":"10.1016\/j.jneuroim.2012.06.003_bb0095","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0197-0186(99)00031-5","article-title":"Unchanged levels of interleukins, neopterin, interferon-\u03b3 and tumor necrosis factor-\u03b1 in cerebrospinal fluid of patients with dementia of the Alzheimer type","volume":"34","author":"Engelborghs","year":"1999","journal-title":"Neurochem. Int."},{"issue":"8","key":"10.1016\/j.jneuroim.2012.06.003_bb0100","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1136\/jnnp.45.8.759","article-title":"Viruses and Alzheimer's disease","volume":"45","author":"Esiri","year":"1982","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.jneuroim.2012.06.003_bb0105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/nbdi.1998.0176","article-title":"Calcium responses in fibroblasts from asymptomatic members of Alzheimer's disease families","volume":"5","author":"Etcheberrigaray","year":"1998","journal-title":"Neurobiol. Dis."},{"issue":"11","key":"10.1016\/j.jneuroim.2012.06.003_bb0110","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/JGP.0b013e3181e70c05","article-title":"Association study of interferon-\u03b3, cytosolic phospholipase A2, and cyclooxygenase-2 gene polymorphisms in Alzheimer disease","volume":"18","author":"Feh\u00e9r","year":"2010","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"3","key":"10.1016\/j.jneuroim.2012.06.003_bb0115","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/01.jcp.0000125683.74595.2f","article-title":"Alzheimer patients treated with an AchE inhibitor show higher IL-4 and lower IL-1\u03b2 levels and expression in peripheral blood mononuclear cells","volume":"24","author":"Gambi","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.jneuroim.2012.06.003_bb0120","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.neuropsychologia.2004.06.007","article-title":"Cholinergic\u2013serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease","volume":"43","author":"Garcia-Alloza","year":"2005","journal-title":"Neuropsychologia"},{"issue":"2","key":"10.1016\/j.jneuroim.2012.06.003_bb0125","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1006\/brbi.1993.1018","article-title":"The inhibitory effect of interferon-\u03b1 on the serotonin-induced impairment of human NK cell activity in whole blood","volume":"7","author":"Garssadi","year":"1993","journal-title":"Brain Behav. Immun."},{"issue":"7","key":"10.1016\/j.jneuroim.2012.06.003_bb0130","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1089\/jir.2005.25.395","article-title":"Dopamine fails to regulate activation of peripheral blood lymphocytes from multiple sclerosis patients: effects of IFN-\u03b2","volume":"25","author":"Giorelli","year":"2005","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.jneuroim.2012.06.003_bb0135","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.jneuroim.2012.06.003_bb0140","first-page":"611","article-title":"Management of the behavioral and psychological symptoms of dementia","volume":"2","author":"Hersch","year":"2007","journal-title":"Clin. Interv. Aging"},{"issue":"Suppl. 3","key":"10.1016\/j.jneuroim.2012.06.003_bb0145","first-page":"S269","article-title":"Diagnosis of neurometabolic and neurodegenerative diseases by cutaneous biopsy","volume":"25","author":"Idoate-Gastearena","year":"1997","journal-title":"Rev. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2012.06.003_bb0150","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0304-3940(93)90199-U","article-title":"Dopamine D2 receptors in the hippocampus and amygdala in Alzheimer's disease","volume":"154","author":"Joyce","year":"1993","journal-title":"Neurosci. Lett."},{"issue":"6","key":"10.1016\/j.jneuroim.2012.06.003_bb0155","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0893-133X(98)00044-X","article-title":"Loss of dopamine D2 receptors in Alzheimer's disease with parkinsonism but not Parkinson's or Alzheimer's disease","volume":"19","author":"Joyce","year":"1998","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.jneuroim.2012.06.003_bb0160","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1460-9568.2003.02716.x","article-title":"Hippocampal dopamine D2 receptors correlate with memory functions in Alzheimer's disease","volume":"18","author":"Kemppainen","year":"2003","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.jneuroim.2012.06.003_bb0165","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.brainres.2006.10.049","article-title":"Immunohistochemical localization of dopamine receptor subtypes (D1R\u2013D5R) in Alzheimer's disease brain","volume":"1131","author":"Kumar","year":"2007","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.jneuroim.2012.06.003_bb0170","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.mad.2005.09.016","article-title":"Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer's disease","volume":"127","author":"Lanari","year":"2006","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.jneuroim.2012.06.003_bb0175","unstructured":"Llano, D.A., Li, J., Waring, J.F., Ellis, T., Devanarayan, V., Witte, D.G., Lenz, R.A., in press. Cerebrospinal fluid cytokine dynamics differ between Alzheimer disease patients and elderly controls. Alzheimer Dis. Assoc. Disord."},{"issue":"3","key":"10.1016\/j.jneuroim.2012.06.003_bb0180","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.pnpbp.2010.12.017","volume":"35","author":"Maes","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.jneuroim.2012.06.003_bb0185","doi-asserted-by":"crossref","first-page":"779","DOI":"10.4067\/S0034-98872011000600013","article-title":"Herpes simplex virus type 1 as risk factor associated to Alzheimer disease","volume":"139","author":"Martin","year":"2011","journal-title":"Rev. Med. Chil."},{"issue":"4","key":"10.1016\/j.jneuroim.2012.06.003_bb0190","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1755-5949.2010.00175.x","article-title":"Beyond the cholinergic hypothesis: do current drugs work in Alzheimer's disease?","volume":"16","author":"Martorana","year":"2010","journal-title":"CNS Neurosci. Ther."},{"issue":"4","key":"10.1016\/j.jneuroim.2012.06.003_bb0195","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0306-4530(01)00062-2","article-title":"Mental deterioration correlates with response of natural killer (NK) cell activity to physiological modifiers in patients with short history of Alzheimer's disease","volume":"27","author":"Masera","year":"2002","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jneuroim.2012.06.003_bb0200","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1017\/S1462399411002006","article-title":"Emerging roles of pathogens in Alzheimer disease","volume":"13","author":"Mikl\u00f3ssy","year":"2011","journal-title":"Expert Rev. Mol. Med."},{"issue":"3","key":"10.1016\/j.jneuroim.2012.06.003_bb0205","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1212\/WNL.46.3.791","article-title":"Decrease of the D3 dopamine receptor mRNA expression in lymphocytes from patients with Parkinson's disease","volume":"46","author":"Nagai","year":"1996","journal-title":"Neurology"},{"issue":"5\u20136","key":"10.1016\/j.jneuroim.2012.06.003_bb0210","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1290\/0407048.1","article-title":"Opposite effects of serotonin and interferon-\u03b1 on the membrane potential and function of human natural killer cells","volume":"41","author":"Ol\u00e1h","year":"2005","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"issue":"16","key":"10.1016\/j.jneuroim.2012.06.003_bb0215","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0047-6374(01)00316-5","article-title":"Pharmacological treatment of non-cognitive disturbances in dementia disorders","volume":"122","author":"Parnetti","year":"2001","journal-title":"Mech. Ageing Dev."},{"issue":"4","key":"10.1016\/j.jneuroim.2012.06.003_bb0220","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.neurobiolaging.2010.06.011","article-title":"Association of serotonin and dopamine gene pathways with behavioral subphenotypes in dementia","volume":"33","author":"Proitsi","year":"2012","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.jneuroim.2012.06.003_bb0225","doi-asserted-by":"crossref","first-page":"15","DOI":"10.33549\/physiolres.931903","article-title":"Serotonin receptors \u2014 from molecular biology to clinical applications","volume":"60","author":"Pytliak","year":"2011","journal-title":"Physiol. Res."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2012.06.003_bb0230","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jneuroim.2003.11.003","article-title":"Treatment with an acetylcholinesterase inhibitor in Alzheimer patients modulates the expression and production of the pro-inflammatory and anti-inflammatory cytokines","volume":"148","author":"Reale","year":"2004","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.jneuroim.2012.06.003_bb0235","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3233\/JAD-2008-14203","article-title":"Peripheral chemokine receptors, their ligands, cytokines and Alzheimer's disease","volume":"14","author":"Reale","year":"2008","journal-title":"J. Alzheimers Dis."},{"issue":"6","key":"10.1016\/j.jneuroim.2012.06.003_bb0240","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1212\/01.wnl.0000341932.21961.f3","article-title":"Increased striatal dopamine (D2\/D3) receptor availability and delusions in Alzheimer disease","volume":"72","author":"Reeves","year":"2009","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jneuroim.2012.06.003_bb0245","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0278-5846(02)00253-1","article-title":"Decrease of the D4 dopamine receptor messenger RNA expression in lymphocytes from patients with major depression","volume":"26","author":"Rocca","year":"2002","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.jneuroim.2012.06.003_bb0250","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.schres.2005.06.010","article-title":"Expression of D3 and D4 dopamine receptors in leukocytes is related to schizophrenic symptoms","volume":"80","author":"Rodrigues","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jneuroim.2012.06.003_bb0255","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer's disease: genes, proteins and therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiol. Rev."},{"issue":"2","key":"10.1016\/j.jneuroim.2012.06.003_bb0260","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.brainresbull.2005.12.001","article-title":"Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: a microdialysis study","volume":"69","author":"Shearman","year":"2006","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.jneuroim.2012.06.003_bb0265","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1749-6632.2000.tb05399.x","article-title":"Overproduction of IFN-gamma and TNF-alpha from natural killer (NK) cells is associated with abnormal NK reactivity and cognitive derangement in Alzheimer's disease","volume":"917","author":"Solerte","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.jneuroim.2012.06.003_bb0270","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1017\/S1041610200006645","article-title":"Serotonin 5-HT2A receptor binding in platelets from patients with Alzheimer's disease or vascular dementia","volume":"12","author":"Spigset","year":"2000","journal-title":"Int. Psychogeriatr."},{"issue":"6","key":"10.1016\/j.jneuroim.2012.06.003_bb0275","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1016\/j.ajpath.2011.02.012","article-title":"Inflammation induced by infection potentiates tau pathological features in transgenic mice","volume":"178","author":"Sy","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jneuroim.2012.06.003_bb0280","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1126\/science.286.5448.2352","article-title":"Microglial activation resulting from CD40\u2013CD40L interaction after \u03b2-amyloid stimulation","volume":"286","author":"Tan","year":"1999","journal-title":"Science (Wash DC)"},{"issue":"10","key":"10.1016\/j.jneuroim.2012.06.003_bb0285","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.biopsych.2008.07.019","article-title":"All-or-nothing type biphasic cytokine production of human lymphocytes after exposure to Alzheimer's \u03b2-amyloid peptide","volume":"64","author":"Teixeira","year":"2008","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.jneuroim.2012.06.003_bb0290","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.pnpbp.2008.10.020","article-title":"The leukocytes expressing DARPP-32 are reduced in patients with schizophrenia and bipolar disorder","volume":"33","author":"Torres","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jneuroim.2012.06.003_bb0295","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0065-2776(08)60664-1","article-title":"Biology of natural killer cells","volume":"47","author":"Trinchieri","year":"1989","journal-title":"Adv. Immunol."},{"issue":"4","key":"10.1016\/j.jneuroim.2012.06.003_bb0300","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1159\/000080958","article-title":"Decreased levels of dopamine D3 receptor mRNA in schizophrenic and bipolar patients","volume":"50","author":"Vogel","year":"2004","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.jneuroim.2012.06.003_bb0305","first-page":"51","article-title":"Late life depression with cognitive impairment: evaluation and treatment","volume":"4","author":"Wilkins","year":"2009","journal-title":"Clin. Interv. Aging"},{"issue":"1","key":"10.1016\/j.jneuroim.2012.06.003_bb0310","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0162-3109(96)00111-7","article-title":"Tricyclic antidepressants inhibit IL-6, IL-1\u03b2 and TNF-\u03b1 release in human blood monocytes and IL-2 and interferon-\u03b3 in T cells","volume":"34","author":"Xia","year":"1996","journal-title":"Immunopharmacology"},{"issue":"6","key":"10.1016\/j.jneuroim.2012.06.003_bb0315","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/ana.410170608","article-title":"Nucleus raphe dorsalis in Alzheimer's disease: neurofibrillary tangles and loss of large neurons","volume":"17","author":"Yamamoto","year":"1985","journal-title":"Ann. Neurol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572812001853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572812001853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:19:16Z","timestamp":1759047556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572812001853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":63,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0165572812001853"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2012.06.003","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disease-specific expression of the serotonin-receptor 5-HT2C in natural killer cells in Alzheimer's dementia","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2012.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}